95 related articles for article (PubMed ID: 22320866)
1. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.
Wang M; Lang X; Cui S; Zou L; Cao J; Wang S; Wu X
DNA Cell Biol; 2012 Jun; 31(6):975-82. PubMed ID: 22320866
[TBL] [Abstract][Full Text] [Related]
2. Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.
Zhao Y; Ma Y; Fang Y; Liu L; Wu S; Fu D; Wang X
Mol Genet Metab; 2012 Jan; 105(1):141-8. PubMed ID: 22030099
[TBL] [Abstract][Full Text] [Related]
3. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
Lu C; Gao Y; Zhou H; Tian H
Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
[TBL] [Abstract][Full Text] [Related]
4. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.
Mackness B; Durrington P; McElduff P; Yarnell J; Azam N; Watt M; Mackness M
Circulation; 2003 Jun; 107(22):2775-9. PubMed ID: 12756158
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
[TBL] [Abstract][Full Text] [Related]
6. Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Mackness B; Mackness M
Clin Biochem; 2019 Mar; 65():21-23. PubMed ID: 30659791
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
Mackness M; Mackness B
Free Radic Biol Med; 2004 Nov; 37(9):1317-23. PubMed ID: 15454272
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
9. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.
Wang M; Lang X; Zou L; Huang S; Xu Z
Atherosclerosis; 2011 Feb; 214(2):377-85. PubMed ID: 21146823
[TBL] [Abstract][Full Text] [Related]
10. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
[TBL] [Abstract][Full Text] [Related]
12. The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Domagała TB; Łacinski M; Trzeciak WH; Mackness B; Mackness MI; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):4-10. PubMed ID: 17543199
[TBL] [Abstract][Full Text] [Related]
13. High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.
Mackness B; Hine D; McElduff P; Mackness M
Atherosclerosis; 2006 Jun; 186(2):396-401. PubMed ID: 16140307
[TBL] [Abstract][Full Text] [Related]
14. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
15. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
[TBL] [Abstract][Full Text] [Related]
16. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O
Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies.
Zhang H; Mo X; Hao Y; Huang J; Lu X; Cao J; Gu D
Am J Med Sci; 2013 Jun; 345(6):455-61. PubMed ID: 23123561
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Zapolski T
Med Sci Monit; 2014 Apr; 20():594-600. PubMed ID: 24721823
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 polymorphism and coronary heart disease susceptibility: a meta-analysis involving 47,596 subjects.
Zhou D; Hu W; Wang Q; Jin Y
Heart Lung Circ; 2014 Jun; 23(6):578-85. PubMed ID: 24525147
[TBL] [Abstract][Full Text] [Related]
20. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
